ClinicalTrials.Veeva

Menu

Sense of Coherence and Empowerment at Patients With MUPS

U

University of Oslo

Status

Enrolling

Conditions

Medically Unexplained Symptoms
Sense of Coherence

Treatments

Behavioral: Metacognitive Therapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a study on Metacognitive therapy in general practice in Norway. The intervention is a small pilot study to examine whether Metacognitive therapy is feasible in an ordinary general practice. Will the physicians be capable to learn and provide the therapy method for their patients with MUPS and is is possible to implement this in an ordinary general practice routine? Both physicians and their patients will be asked to respond to a questionnaire on perceived utility of the treatment.

Full description

Metacognitive therapy is different from Cognitive therapy in the sense that it adresses the individual's attention towards potential worries and threats and also the management performed by the patient to avoid these. Also the individual's capacity to produce empowerment to manage these threats are of interest in the talks with the health care provider. - In this study, General Practitioners with specific training in Metacognitive therapy will be asked to recruit 2-3 patients with Medically Unexplained Physical Symptoms each and invite them to a series of Metacognitive Therapy. The patients and physicians will then provide their assessments of the treatment on a number of questionnaires. To explore the Sense of coherence and Empowerment among patients with Medically Unexplained Symptoms, the physicians will be asked to recruit six patients each to respond to a questionnaire.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • MUPS: Medically Unexplained Physical Symptoms
  • somatic and mental examination sufficiently accomplished
  • ongoing symptoms
  • more than three months of disabeling symptoms

Exclusion criteria

  • not capable to respond on a written questionnaire in Norwegian

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Intervention
Experimental group
Description:
All patients recieve active treatment
Treatment:
Behavioral: Metacognitive Therapy

Trial contacts and locations

1

Loading...

Central trial contact

Ingunn Leeber, MD; Erik L. Werner, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems